No Data
No Data
Express News | Northeast Pharmaceutical Group plans to donate 10 million yuan worth of earthquake relief supplies to the earthquake-stricken areas in Dingri County.
Northeast Pharmaceutical Gets Nod to Market Empagliflozin
Express News | Northeast Pharmaceutical Group: The application for the listing of the Active Pharmaceutical Ingredient Empagliflozin has been approved.
Express News | This week, 10 listed companies announced the details related to share repurchase and additional loan disclosures. Hangzhou Hikvision Digital Technology plans to use its own funds and special loans of 2 billion to -2.5 billion yuan to repurchase shares.
Express News | Summary of Shareholding announcements丨The controlling shareholder and Director of this company plan to reduce their shareholding by 4%.
Northeast Pharmaceutical Group (000597.SZ): The concerted parties of the controlling Shareholder plan to increase their Shareholding by 0.075 billion yuan to -0.15 billion yuan in the company's shares.
Glory Financial reported on December 10th that Northeast Pharmaceutical Group (000597.SZ) announced that the company's controlling Shareholder, Liaoning China Fangda Group Industrial Co., Ltd. (referred to as "China Fangda Group"), and its concerted party, Jiangxi Fangda Steel Group Co., Ltd. (hereinafter referred to as "Fangda Steel/Shareholding entity"), plan to increase their shareholding in the company within six months from the date of the announcement, with a planned increase of no less than 75 million yuan and no more than 150 million yuan. The funds for this increase will come from Fangda Steel's own funds and special loans.